In 2012, Envivo’s experimental Alzheimer’s drugs improved cognitive function as the company won a Fierce BioTech Award. Learn about and participate in their newest Phase-2
BioWorld’s top 10 stories for 2012 included the puzzling outcome of some massive Alzheimer’s trials. Find out how we are more-sure-than-ever of what ought to
Merck announced it is enrolling volunteers for the EPOCH clinical trial. Read details on their highly promising MK-8931 treatment for mild-to-moderate Alzheimer’s disease. Find out
See a robot with a biological brain made of cultured neurons. Find out why this may hold a key to treating dementia, stroke & brain injury.
VIDEO & ARTICLE Solanezumab slowed Alzheimer’s by 30% in a trial earlier this year. Find out what it’s maker, Ely Lilly, plans for the next step.
VIDEO + ARTICLE Researchers at Johns Hopkins Medicine surgically implanted a pacemaker-like device into the brain of a patient in the early stages of Alzheimer’s
VIDEO & ARTICLE In trials, the most effective Alzheimer’s treatment so far is IVIG. At $50,000 per year, learn how scientists hope to bring down
Learn how Medicare has just added payment for more dementia therapy. Previously, therapy had to improve a condition. Now, maintaining it or even preventing & slowing deterioration are covered.
VIDEO Watch this Wall Street Journal interview on why Dr. Wischik sees tau as a more worthwhile anti-Alzheimer’s target than plaque. Learn more about TauRx’
Alzheimer’s & Dementia Weekly is providing its regular stream of news services without interruption. Catch all the latest updates here, on Facebook or on Twitter.
Learn how a personalized Alzheimer’s Weekly Newsletter can boost donations in your not-for-profit dementia organization.
INNOVATION – VIDEO: A big supermarket launched a ‘relaxed’ checkout lane to make life a little less stressful for people with dementia and other vulnerable people.
VIDEO + ARTICLE: Residential areas with more green space were associated with faster thinking, better attention, and higher overall cognitive function in a federal study. Learn more.
What are the early symptoms of Alzheimer’s? When to get a professional evaluation.
SHORT-TERM MEMORY lapses are obvious signs of Alzheimer’s, but other tell-tale signals begin to show much earlier. Learn how to look for semantic impairments, such as simple questions about size.
Three important dementia studies focus on HS-AGING, a type of dementia almost as common as Alzheimer’s in the 85+ group. Yet few people have heard of it. Why? What makes it different?
An intriguing study of 120 grandmothers might surprise you. Doctors know socially engaged people have better cognition and less dementia. But can a person get too much of a good thing? What’s the right balance?
No spam, only news and updates.
